<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Velcade; Bortezomib" /><meta name="IX" content="Velcade; Bortezomib" /><title>Velcade®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="128315.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="128315.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=128315.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4676.htm">8.1 Cytotoxic drugs</a> &gt; <a href="4758.htm">8.1.5 Other antineoplastic drugs</a> &gt; <a href="128312.htm">Bortezomib</a> &gt; <a href="128313.htm">BORTEZOMIB</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="128312.htm" title="Previous: Bortezomib">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="218117.htm" title="Next: Catumaxomab">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303026.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21105-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Bortezomib</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: B &gt; Interactions of Bortezomib</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="128312.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="128313.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BORTEZOMIB</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Bortezomib</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a508004.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0002s0139.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/21105-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01351.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bortezomib</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; B &gt; BO</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E10E3E0R0D1715.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Bortezomib</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; B</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_128313">BORTEZOMIB</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i1116.htm" title="Go to appendix 1">Bortezomib</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see <a title="monograph-family: Bortezomib" href="128312.htm#_128312">notes above</a></p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="section: Cytotoxic drugs" href="4676.htm#_4676">section 8.1</a>; cardiovascular disease; pulmonary disease (chest x-ray recommended before
treatment—discontinue if interstitial lung disease develops); consider antiviral prophylaxis for herpes zoster infection; history of seizures; amyloidosis; risk of neuropathy—consult product literature; monitor blood-glucose concentration in patients on
oral antidiabetics; <b>interactions:</b> Appendix
1 (bortezomib)</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">acute diffuse infiltrative pulmonary
disease; pericardial disease</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">reduce dose in moderate to severe impairment—consult
product literature</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">no information available for creatinine clearance less
than 20 mL/minute/1.73 m<sup>2</sup></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">manufacturer advises effective contraception during
and for 3 months after treatment in men or women—toxicity in <i>animal</i> studies; see also <a title="target-block: Cytotoxic drugs: Reproductive function" href="100100.htm#_100100.2">Pregnancy and Reproductive
Function</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">discontinue breast-feeding</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="topic: Side-effects of cytotoxic drugs" href="100100.htm#_100100">section 8.1</a>; also gastro-intestinal disturbances
including constipation (cases of ileus reported), taste disturbance,
dry mouth, decreased appetite; postural hypotension, hypertension,
haematoma, phlebitis, chest pain, oedema; dyspnoea, cough; confusion,
depression, insomnia, anxiety, peripheral neuropathy, paraesthesia,
headache, dizziness, tremor, asthenia, fatigue; reactivation of herpes
zoster infection, influenza-like symptoms; renal impairment, dysuria;
dehydration, hypokalaemia, hyperglycaemia; muscle cramps, arthralgia,
bone pain; blurred vision, eye pain; epistaxis; urticaria, pruritus,
erythema, dry skin, eczema, rash, increased sweating; <i>less
commonly</i> syncope, seizures; reversible posterior leucoencephalopathy
syndrome (discontinue treatment), toxic epidermal necrolysis, Sweet’s
syndrome, and vasculitic rash also reported</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See <a title="BNF:target-block: Doses of cytotoxic drugs" href="4676.htm#_215549">Doses</a></p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_128315" style="margin: 0 0 0 20px;"><h1 class="title">Velcade®<span> (<a href="appendix-112803-J.htm#m401">Janssen</a>)</span> <a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_s.png" alt="Black triangle" /></a> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, powder for reconstitution,
bortezomib (as mannitol boronic ester), net price 3.5-mg vial = £762.38</div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="128312.htm">Previous: Bortezomib</a> | <a class="top" href="128315.htm#">Top</a> | <a accesskey="]" href="218117.htm">Next: Catumaxomab</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>